Skip to main content

Table 1 Patient characteristics

From: Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience

 

All

Male

Female

Age (years)

63.1 (49.1–78.7)

65.0 (56.9–75.8)

61.6 (49.1–78.7)

Weight (kg)

75.5 (57–102)

81 (65–96)

71.5 (57–102)

Height (cm)

167 (154–192)

174 (167–192)

164 (154–178)

BMI (kg/m2)

26.0 (20.6–35.3)

25.6 (20.6–34.4)

26.1 (21.7–35.3)

BSA (m2)

1.88 (1.59–2.19)

2.04 (1.75–2.07)

1.80 (1.59–2.19)

Dose of melphalan (mg)

183 (150–220)

206 (192–220)

171 (150–199)

  1. Of note: all demographic data referred to the time of the first CS-PHP. All values were given as the median with the range in parenthesis. BMI Body-Mass-Index. BSA Body Surface Area
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us